Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach

Welcome to the first installment of an exclusive 8-part ASTCT Talks series, supported by an educational grant from Sanofi US. In this series, ASTCT President Dr. Corey Cutler speaks with authors from each article in the latest ⁠ASTCT Journal of Transplantation and Cellular Therapy GVHD supplement⁠.

In this opening episode, Dr. Cutler is joined by Dr. Katie Luo, a leading ophthalmologist, to discuss the complexities of ocular GVHD, why it goes beyond “just dry eye,” and how an integrated, multidisciplinary approach can offer better patient outcomes.

For further insights, read Dr. Luo’s full article, ⁠“Understanding Ocular Graft-versus-Host Disease to Facilitate an Integrated Multidisciplinary Approach”⁠, and stay tuned as Dr. Cutler delves into each article with its author, providing a comprehensive guide on GVHD management through this entire supplement series.